MediPharm Labs Corp. (TSE:LABS – Get Free Report)’s share price reached a new 52-week high on Monday . The stock traded as high as C$0.12 and last traded at C$0.11, with a volume of 453968 shares changing hands. The stock had previously closed at C$0.11.
MediPharm Labs Price Performance
The stock has a market capitalization of C$41.50 million, a price-to-earnings ratio of -3.44 and a beta of 0.88. The company’s 50-day simple moving average is C$0.07 and its 200-day simple moving average is C$0.07. The company has a debt-to-equity ratio of 1.45, a current ratio of 3.21 and a quick ratio of 3.10.
About MediPharm Labs
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
Further Reading
- Five stocks we like better than MediPharm Labs
- What is the FTSE 100 index?
- Energy Transfer: Powering Data With Dividends and Diversification
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Qualcomm Stock Is Coiling for a Breakout
- How to Read Stock Charts for Beginners
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
